|
|||||||||
|
||
![]() |
Agenda
View speakers
The 22nd Annual Meeting of the Groups Studying the Structures of AIDS-Related Systems and Their Application to Targeted Drug Design06/26/2008 - 06/27/2008Agenda
THURSDAY, JUNE 26
8:00 – 8:30 Registration
8:30 – 8:35 Ravi Basavappa (NIGMS)
Welcome/Opening Remarks
8:35 – 945 Angela Gronenborn (University of Pittsburgh)
The Pittsburgh Center for HIV Protein Interactions: Studies of HIV infection, post- entry to integration
Chris Aiken (Vanderbilt University)
Structural Analysis of Capsid – Cyclophilin A interactions: Evidence for a Novel Restriction
Simon Watkins (University of Pittsburgh)
Tools and Methods for Imaging HIV in Living Cells
9:45 – 10:55 Wes Sundquist (University of Utah)
The CHEETAH Center
10:55 – 11:15 BREAK
11:15 – 12:25 Alan Frankel (University of California, San Francisco)
HARC Center Overview and Progress on Tat and Rev
Complexes
Matija Peterlin (University of California, San Francisco)
HIV Accessory and Regulatory Complexes: Tat, Nef, Vif
Robert Stroud (University of California, San Francisco)
HIV Integrase - DNA and Complexes
12:25 – 1:30 LUNCH
1:30 – 3:30 POSTER SESSION
3:30 – 4:10 Celia Schiffer (University of Massachusetts Medical School)
Targeting Drug Resistance in HIV-1 Protease
4:10 – 4:40 Stephen Goff (Columbia University/ HHMI)
Retroviral Restriction Factors: New Aspects of Innate Immunity
4:40 – 5:00 Yong Xiong (Yale University)
Structural Insight into the HIV Vif SOCS Box and Its Role in Human E3 Ubiquitin Ligase Assembly
5:00 – 5:20 Stanley Opella (University of California, San Diego)
Structure, Dynamics, and Drug-binding to the Viroporins Vpu of
HIV-1 and p7 of HCV
5:20 Adjourn for day
FRIDAY, JUNE 27
8:30 – 8:35 Diana Finzi (National Institute of Allergy and Infectious Diseases)
Introduction to special session on genome-wide siRNA – based
screening of HIV – host interactions
8:35 – 9:05 Derek Dykxhoorn (Harvard Medical School)
A functional genomic approach for the identification of host proteins required for HIV infection
9:05 – 9:35 Amy Espeseth (Merck and Company)
Novel Host Factor Requirements for HIV Replication Identified via
siRNA screens
9:35 – 10:05 Sumit Chanda (The Burnham Institute)
Global analysis and Characterization of Host-Pathogen Interactions which regulate early stage HIV-1 replication
10:05 – 10:25 BREAK
10:25 – 10:55 Sriram Subramaniam (National Cancer Institute)
3D structure of native HIV-1 gp120 trimers and mechanisms of
cellular entry
10:55 – 11:25 Hiroshi Matsuo (University of Minnesota)
Structural Studies of the Deaminase Domain of APOBEC3G
11:25 – 12:05 Art Olson (The Scripps Research Institute)
Resistance Driven Structural Design for HIV Therapeutics
– Program Overview
Bruce Torbett (The Scripps Research Institute)
Resistance-Driven Approaches to HIV Protease Inhibition:
Structure and Biology
Richard Belew (University of California, San Diego)
Analysis of clinically-observed HIV evolution in response to alternative inhibitors via a probabilistic graph
Valery Fokin (The Scripps Research Institute)
Novel 1,2,3-Triazole-Based Inhibitors of HIV Protease
12:05 – 1:00 LUNCH
1:00 – 2:00 POSTER SESSION
2:00 – 2:20 Rob Rizzo (Stony Brook University)
Origins of Resistance to Peptide Inhibitors of HIVgp41
2:20 – 2:40 David Green (Stony Brook University)
Carbohydrate recognition by anti-viral proteins
2:40 – 3:20 Irwin Chaiken (Drexel University)
Structure-Based Antagonism of HIV-1 Envelope Function in
Cell Entry
Joseph Sodroski (Harvard Medical School)
Interaction of Small-Molecule CD4 Mimics with a Highly
Conserved Pocket on the Human Immunodeficiency
Virus gp120 Envelope Glycoprotein
3:20 – 3:40 BREAK
3:40 – 4:00 TN Bhat (National Institute of Standards and Technology)
A Cross-referencing Web Resource of Pre-clinical Data for AIDS
4:00 – 4:20 Miriam Gochin (Touro University)
Exploration of small molecule libraries for gp41 inhibitors using a rapid fluorescence screening assay
4:20 – 4:40 Sergei Nekhai (Howard University)
Regulation of HIV-1 Transcription by cellular iron and hypoxia:
role of CDK2 and PP1
4:40 – 5:00 Rui Gong (National Cancer Institute)
Engineered Human Antibody Constant Domains with Increased
Stability
5:00 Adjourn Meeting
|
|
National Institute of General Medical Sciences - 45
Center Drive MSC 6200 - Bethesda, MD 20892-6200 Tel: 301-496-7301 - E-mail: wds@nigms.nih.gov |
| Version: 1.2.0 | Privacy Statement |